Janckila AJ - Search Results

1

Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.

Lu KC, Tseng CF, Wu CC, Yeung LK, Chen JS, Chao TY, Janckila AJ, Yam LT, Chu P. Lu KC, et al. Among authors: janckila aj. Blood Purif. 2006;24(5-6):423-30. doi: 10.1159/000094899. Epub 2006 Aug 4. Blood Purif. 2006. PMID: 16888370 Clinical Trial.

2

Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.

Chao TY, Ho CL, Lee SH, Chen MM, Janckila A, Yam LT. Chao TY, et al. J Biomed Sci. 2004 Jul-Aug;11(4):511-6. doi: 10.1007/BF02256100. J Biomed Sci. 2004. PMID: 15153786

3

Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis.

Chu P, Chao TY, Lin YF, Janckila AJ, Yam LT. Chu P, et al. Among authors: janckila aj. Am J Kidney Dis. 2003 May;41(5):1052-9. doi: 10.1016/s0272-6386(03)00203-8. Am J Kidney Dis. 2003. PMID: 12722040

4

Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.

Chen CJ, Chao TY, Janckila AJ, Cheng SN, Ku CH, Chu DM. Chen CJ, et al. Among authors: janckila aj. J Pediatr Endocrinol Metab. 2005 Jan;18(1):55-62. doi: 10.1515/jpem.2005.18.1.55. J Pediatr Endocrinol Metab. 2005. PMID: 15679069

5

Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.

Chao TY, Yu JC, Ku CH, Chen MM, Lee SH, Janckila AJ, Yam LT. Chao TY, et al. Among authors: janckila aj. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):544-50. Clin Cancer Res. 2005. PMID: 15701839

6

Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.

Chao TY, Lee SH, Chen MM, Neustadt DH, Chaudhry UA, Yam LT, Janckila AJ. Chao TY, et al. Among authors: janckila aj. Clin Chim Acta. 2005 Sep;359(1-2):132-40. doi: 10.1016/j.cccn.2005.03.039. Clin Chim Acta. 2005. PMID: 15993395

7

Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.

Wu YY, Janckila AJ, Ku CH, Yu CP, Yu JC, Lee SH, Liu HY, Yam LT, Chao TY. Wu YY, et al. Among authors: janckila aj. BMC Cancer. 2010 Apr 23;10:158. doi: 10.1186/1471-2407-10-158. BMC Cancer. 2010. PMID: 20416078 Free PMC article.

8

Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.

Chao TY, Wu YY, Janckila AJ. Chao TY, et al. Among authors: janckila aj. Clin Chim Acta. 2010 Nov 11;411(21-22):1553-64. doi: 10.1016/j.cca.2010.06.027. Epub 2010 Jul 1. Clin Chim Acta. 2010. PMID: 20599857 Review.

9

Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.

Yao NS, Wu YY, Janckila AJ, Ku CH, Hsieh AT, Ho CL, Lee SH, Chao TY. Yao NS, et al. Among authors: janckila aj. Clin Chim Acta. 2011 Jan 14;412(1-2):181-5. doi: 10.1016/j.cca.2010.09.038. Epub 2010 Oct 7. Clin Chim Acta. 2011. PMID: 20932965

10

The correlation between a chronic inflammatory marker Tartrate-resistant acid phosphatase 5a with cancer cachexia.

Wu YY, Chao TY, Liu HY, Huang TC, Chen JH, Dai MS, Janckila A, Lai SW, Chang PY. Wu YY, et al. J BUON. 2015 Jan-Feb;20(1):325-31. J BUON. 2015. PMID: 25778334 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters